The financials show that HHSE management has been utilizing supplier credit lines for most of their marketing costs (Deluxe, Technicolor, AOL, Accutrak, all key vendors). IMHO, using vendor credit lines is far better than issuing equity shares. Other People's Money as they say, but not the shareholders. Cash flow is always a struggle for indie film companies and vendor lawsuits and judgments looked to be a big issue for HHSE in 2013-2014. Clearly not an ideal scenario. But I'm not seeing listings of new vendor litigation since then except the Redbull license fee dispute in CA, which seems like an easy win for HHSE. The company seems to be judgment-proof in that none of these old lawsuits have challenged the stubbornness of the HHSE mgrs to survive and persevere. The company is 23-years old (1993), which is incredibly rare for an OTC issuer. Definitely not the same rules apply as with a start up. And with CIDM as their new distribution partner I would expect some significant improvements soon.